Early complications following haematopoietic SCT in children View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-06

AUTHORS

M Miano, M Faraci, G Dini, P Bordigoni

ABSTRACT

Early complications can be defined as those occurring within 100 days after transplant. Both epithelial and endothelial damage represent the pathogenetic basis for the onset of the most frequent complications. Clinical features related to endothelial damage depend on the involved district or on the grade and type of general distribution. Veno-occlusive disease (VOD) most often occurs within the first 20 days of haematopoietic SCT (HSCT) and is characterized by the obstruction of small intrahepatic venules and is caused by an initial injury of the sinusoid endothelial cells. The incidence in children ranges between 27 and 40%, and symptoms include hepatomegaly, portal hypertension and ascites. Early intervention with defibrotide (DF) proved to be effective for the treatment; however, overall mortality ranges between 20 and 50%. Thrombotic microangiopathy (TAM) incidence is 4-13%. It is often associated with the use of CYA or tacrolimus, and symptoms include haemolytic anaemia, thrombocytopenia and renal and/or central nervous system impairment. Treatment includes plasmapheresis and supportive care. The promising role of DF needs to be confirmed. The onset of engraftment syndrome may occur 1 or 2 days before the neutrophil count in peripheral blood increases. Clinical symptoms include fever not related to infection, respiratory involvement with pulmonary infiltrates or hypoxia and skin rash. Treatment consists of steroid administration for a few days. Haemorrhagic cystitis (HC) may occur early or later following transplant. Early-onset HC is related to mucosal damage caused by the catabolites of chemotherapy drugs, and late-onset HC is mostly caused by viral infections. The incidence ranges between 1 and 25%. Clinical symptoms include haematuria and dysuria without infections. Treatment includes hyperhydration and platelet support. In case of vescical clots, bladder irrigation is indicated. In advanced cases, hyperbaric oxygen administration or surgery may be useful. The use of cidofovir for BK virus-related HC seems encouraging, but further studies are needed to confirm its real efficacy. More... »

PAGES

bmt200853

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bmt.2008.53

DOI

http://dx.doi.org/10.1038/bmt.2008.53

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1007035603

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18545243


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endothelium, Vascular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatic Veno-Occlusive Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation Conditioning", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Istituto Giannina Gaslini", 
          "id": "https://www.grid.ac/institutes/grid.419504.d", 
          "name": [
            "Department Haematology/Oncology, G. Gaslini Children's Research Institute, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miano", 
        "givenName": "M", 
        "id": "sg:person.01145466646.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145466646.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Giannina Gaslini", 
          "id": "https://www.grid.ac/institutes/grid.419504.d", 
          "name": [
            "Department Haematology/Oncology, G. Gaslini Children's Research Institute, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Faraci", 
        "givenName": "M", 
        "id": "sg:person.0631565241.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631565241.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Giannina Gaslini", 
          "id": "https://www.grid.ac/institutes/grid.419504.d", 
          "name": [
            "Department Haematology/Oncology, G. Gaslini Children's Research Institute, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dini", 
        "givenName": "G", 
        "id": "sg:person.014507646124.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014507646124.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Regional Universitaire De Dijon", 
          "id": "https://www.grid.ac/institutes/grid.31151.37", 
          "name": [
            "Department of Pediatrics, Hopital d'Enfants, Vandeouvre Les Nancy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bordigoni", 
        "givenName": "P", 
        "id": "sg:person.01261125776.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261125776.69"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bmt.1703015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000251426", 
          "https://doi.org/10.1038/sj.bmt.1703015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1701506", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003184141", 
          "https://doi.org/10.1038/sj.bmt.1701506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1701506", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003184141", 
          "https://doi.org/10.1038/sj.bmt.1701506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1703710", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008363585", 
          "https://doi.org/10.1038/sj.bmt.1703710"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10428199909093722", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009274082"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00688324", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012150954", 
          "https://doi.org/10.1007/bf00688324"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00688324", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012150954", 
          "https://doi.org/10.1007/bf00688324"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbmt.2005.06.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015726375"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbmt.2005.06.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015726375"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.10699", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017260245"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hep.1840190515", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024503731"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(93)91646-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029165763"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood.v98.6.1971", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034351793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0090-4295(82)90633-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035543523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1704252", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037479272", 
          "https://doi.org/10.1038/sj.bmt.1704252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1083-8791(99)70006-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044483054"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.tp.0000230373.82376.46", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050094293"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.tp.0000230373.82376.46", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050094293"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1083-8791(03)00269-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051220843"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.2000.02475.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056733427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-2002-23204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057413625"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082501496", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082689457", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082761874", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083343944", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-06", 
    "datePublishedReg": "2008-06-01", 
    "description": "Early complications can be defined as those occurring within 100 days after transplant. Both epithelial and endothelial damage represent the pathogenetic basis for the onset of the most frequent complications. Clinical features related to endothelial damage depend on the involved district or on the grade and type of general distribution. Veno-occlusive disease (VOD) most often occurs within the first 20 days of haematopoietic SCT (HSCT) and is characterized by the obstruction of small intrahepatic venules and is caused by an initial injury of the sinusoid endothelial cells. The incidence in children ranges between 27 and 40%, and symptoms include hepatomegaly, portal hypertension and ascites. Early intervention with defibrotide (DF) proved to be effective for the treatment; however, overall mortality ranges between 20 and 50%. Thrombotic microangiopathy (TAM) incidence is 4-13%. It is often associated with the use of CYA or tacrolimus, and symptoms include haemolytic anaemia, thrombocytopenia and renal and/or central nervous system impairment. Treatment includes plasmapheresis and supportive care. The promising role of DF needs to be confirmed. The onset of engraftment syndrome may occur 1 or 2 days before the neutrophil count in peripheral blood increases. Clinical symptoms include fever not related to infection, respiratory involvement with pulmonary infiltrates or hypoxia and skin rash. Treatment consists of steroid administration for a few days. Haemorrhagic cystitis (HC) may occur early or later following transplant. Early-onset HC is related to mucosal damage caused by the catabolites of chemotherapy drugs, and late-onset HC is mostly caused by viral infections. The incidence ranges between 1 and 25%. Clinical symptoms include haematuria and dysuria without infections. Treatment includes hyperhydration and platelet support. In case of vescical clots, bladder irrigation is indicated. In advanced cases, hyperbaric oxygen administration or surgery may be useful. The use of cidofovir for BK virus-related HC seems encouraging, but further studies are needed to confirm its real efficacy.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bmt.2008.53", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "S2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "41"
      }
    ], 
    "name": "Early complications following haematopoietic SCT in children", 
    "pagination": "bmt200853", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "2183c4ccf9d037db227bd4d7df96672a894fe8ac970a7b7374cefc09aaa9825f"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18545243"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8702459"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bmt.2008.53"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1007035603"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bmt.2008.53", 
      "https://app.dimensions.ai/details/publication/pub.1007035603"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000360_0000000360/records_118315_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.nature.com/articles/bmt200853"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bmt.2008.53'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bmt.2008.53'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bmt.2008.53'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bmt.2008.53'


 

This table displays all metadata directly associated to this object as RDF triples.

197 TRIPLES      21 PREDICATES      60 URIs      31 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bmt.2008.53 schema:about N0c6f13fb142646dab5446e7a4ac3c77f
2 N1e90455a8d6c4663bb5dd99c23afbcd3
3 N40c85d61ebda43fc8665153627575f98
4 N67bbfb436d7e4435b9efd872c90a377b
5 N6cd12aa340fd45b596837c68010c3162
6 N9aac838bab884a9b99129080bc7085c6
7 Nd1abfde950934304b8d6f11c0a576cc4
8 Nf3f83ac078014526bb8acb6059b92d1c
9 Nf8e84753e578463b9f40ee8b05e8aed3
10 Nfa925a580ad84249b865867000b3a1fb
11 anzsrc-for:11
12 anzsrc-for:1103
13 schema:author N514fe53449234884a54b50893d38a45d
14 schema:citation sg:pub.10.1007/bf00688324
15 sg:pub.10.1038/sj.bmt.1701506
16 sg:pub.10.1038/sj.bmt.1703015
17 sg:pub.10.1038/sj.bmt.1703710
18 sg:pub.10.1038/sj.bmt.1704252
19 https://app.dimensions.ai/details/publication/pub.1082501496
20 https://app.dimensions.ai/details/publication/pub.1082689457
21 https://app.dimensions.ai/details/publication/pub.1082761874
22 https://app.dimensions.ai/details/publication/pub.1083343944
23 https://doi.org/10.1002/hep.1840190515
24 https://doi.org/10.1016/0090-4295(82)90633-1
25 https://doi.org/10.1016/0140-6736(93)91646-4
26 https://doi.org/10.1016/j.bbmt.2005.06.007
27 https://doi.org/10.1016/s1083-8791(03)00269-6
28 https://doi.org/10.1016/s1083-8791(99)70006-6
29 https://doi.org/10.1046/j.1365-2141.2000.02475.x
30 https://doi.org/10.1055/s-2002-23204
31 https://doi.org/10.1097/01.tp.0000230373.82376.46
32 https://doi.org/10.1182/blood.v98.6.1971
33 https://doi.org/10.3109/10428199909093722
34 https://doi.org/10.3324/haematol.10699
35 schema:datePublished 2008-06
36 schema:datePublishedReg 2008-06-01
37 schema:description Early complications can be defined as those occurring within 100 days after transplant. Both epithelial and endothelial damage represent the pathogenetic basis for the onset of the most frequent complications. Clinical features related to endothelial damage depend on the involved district or on the grade and type of general distribution. Veno-occlusive disease (VOD) most often occurs within the first 20 days of haematopoietic SCT (HSCT) and is characterized by the obstruction of small intrahepatic venules and is caused by an initial injury of the sinusoid endothelial cells. The incidence in children ranges between 27 and 40%, and symptoms include hepatomegaly, portal hypertension and ascites. Early intervention with defibrotide (DF) proved to be effective for the treatment; however, overall mortality ranges between 20 and 50%. Thrombotic microangiopathy (TAM) incidence is 4-13%. It is often associated with the use of CYA or tacrolimus, and symptoms include haemolytic anaemia, thrombocytopenia and renal and/or central nervous system impairment. Treatment includes plasmapheresis and supportive care. The promising role of DF needs to be confirmed. The onset of engraftment syndrome may occur 1 or 2 days before the neutrophil count in peripheral blood increases. Clinical symptoms include fever not related to infection, respiratory involvement with pulmonary infiltrates or hypoxia and skin rash. Treatment consists of steroid administration for a few days. Haemorrhagic cystitis (HC) may occur early or later following transplant. Early-onset HC is related to mucosal damage caused by the catabolites of chemotherapy drugs, and late-onset HC is mostly caused by viral infections. The incidence ranges between 1 and 25%. Clinical symptoms include haematuria and dysuria without infections. Treatment includes hyperhydration and platelet support. In case of vescical clots, bladder irrigation is indicated. In advanced cases, hyperbaric oxygen administration or surgery may be useful. The use of cidofovir for BK virus-related HC seems encouraging, but further studies are needed to confirm its real efficacy.
38 schema:genre research_article
39 schema:inLanguage en
40 schema:isAccessibleForFree true
41 schema:isPartOf N1f1b21862bbf4017830e4e27e7de2168
42 N778ec57a7da74f8abc642d919f34195b
43 sg:journal.1096890
44 schema:name Early complications following haematopoietic SCT in children
45 schema:pagination bmt200853
46 schema:productId N67e30a7d2b774605897cb3ea0875cc46
47 Na8736ea404e64d92b70c9f3ea5a9df28
48 Nc95c373d95f6451885c66fb6d2af0405
49 Nca433f40e8664241a333030fe0aa3837
50 Nfe13fa3adbbc46649fbafe5afff3354d
51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007035603
52 https://doi.org/10.1038/bmt.2008.53
53 schema:sdDatePublished 2019-04-11T12:04
54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
55 schema:sdPublisher Ncaa3cd3161a84502a5a30b3f37ec8bfc
56 schema:url http://www.nature.com/articles/bmt200853
57 sgo:license sg:explorer/license/
58 sgo:sdDataset articles
59 rdf:type schema:ScholarlyArticle
60 N0c6f13fb142646dab5446e7a4ac3c77f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Hemorrhage
62 rdf:type schema:DefinedTerm
63 N1e90455a8d6c4663bb5dd99c23afbcd3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Child
65 rdf:type schema:DefinedTerm
66 N1f1b21862bbf4017830e4e27e7de2168 schema:volumeNumber 41
67 rdf:type schema:PublicationVolume
68 N3f8073ed8ad742dfbfda95d8d2ba1b2f rdf:first sg:person.0631565241.41
69 rdf:rest Nd30d95b92c4541398910265444ce1e4e
70 N40c85d61ebda43fc8665153627575f98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Thrombosis
72 rdf:type schema:DefinedTerm
73 N514fe53449234884a54b50893d38a45d rdf:first sg:person.01145466646.39
74 rdf:rest N3f8073ed8ad742dfbfda95d8d2ba1b2f
75 N67bbfb436d7e4435b9efd872c90a377b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Humans
77 rdf:type schema:DefinedTerm
78 N67e30a7d2b774605897cb3ea0875cc46 schema:name dimensions_id
79 schema:value pub.1007035603
80 rdf:type schema:PropertyValue
81 N6cd12aa340fd45b596837c68010c3162 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Transplantation Conditioning
83 rdf:type schema:DefinedTerm
84 N778ec57a7da74f8abc642d919f34195b schema:issueNumber S2
85 rdf:type schema:PublicationIssue
86 N820f13d5829b46ebabec28193dd0aefe rdf:first sg:person.01261125776.69
87 rdf:rest rdf:nil
88 N9aac838bab884a9b99129080bc7085c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Hepatic Veno-Occlusive Disease
90 rdf:type schema:DefinedTerm
91 Na8736ea404e64d92b70c9f3ea5a9df28 schema:name doi
92 schema:value 10.1038/bmt.2008.53
93 rdf:type schema:PropertyValue
94 Nc95c373d95f6451885c66fb6d2af0405 schema:name nlm_unique_id
95 schema:value 8702459
96 rdf:type schema:PropertyValue
97 Nca433f40e8664241a333030fe0aa3837 schema:name pubmed_id
98 schema:value 18545243
99 rdf:type schema:PropertyValue
100 Ncaa3cd3161a84502a5a30b3f37ec8bfc schema:name Springer Nature - SN SciGraph project
101 rdf:type schema:Organization
102 Nd1abfde950934304b8d6f11c0a576cc4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Risk Factors
104 rdf:type schema:DefinedTerm
105 Nd30d95b92c4541398910265444ce1e4e rdf:first sg:person.014507646124.05
106 rdf:rest N820f13d5829b46ebabec28193dd0aefe
107 Nf3f83ac078014526bb8acb6059b92d1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Child, Preschool
109 rdf:type schema:DefinedTerm
110 Nf8e84753e578463b9f40ee8b05e8aed3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Hematopoietic Stem Cell Transplantation
112 rdf:type schema:DefinedTerm
113 Nfa925a580ad84249b865867000b3a1fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Endothelium, Vascular
115 rdf:type schema:DefinedTerm
116 Nfe13fa3adbbc46649fbafe5afff3354d schema:name readcube_id
117 schema:value 2183c4ccf9d037db227bd4d7df96672a894fe8ac970a7b7374cefc09aaa9825f
118 rdf:type schema:PropertyValue
119 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
120 schema:name Medical and Health Sciences
121 rdf:type schema:DefinedTerm
122 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
123 schema:name Clinical Sciences
124 rdf:type schema:DefinedTerm
125 sg:journal.1096890 schema:issn 0268-3369
126 1476-5365
127 schema:name Bone Marrow Transplantation
128 rdf:type schema:Periodical
129 sg:person.01145466646.39 schema:affiliation https://www.grid.ac/institutes/grid.419504.d
130 schema:familyName Miano
131 schema:givenName M
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145466646.39
133 rdf:type schema:Person
134 sg:person.01261125776.69 schema:affiliation https://www.grid.ac/institutes/grid.31151.37
135 schema:familyName Bordigoni
136 schema:givenName P
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261125776.69
138 rdf:type schema:Person
139 sg:person.014507646124.05 schema:affiliation https://www.grid.ac/institutes/grid.419504.d
140 schema:familyName Dini
141 schema:givenName G
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014507646124.05
143 rdf:type schema:Person
144 sg:person.0631565241.41 schema:affiliation https://www.grid.ac/institutes/grid.419504.d
145 schema:familyName Faraci
146 schema:givenName M
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631565241.41
148 rdf:type schema:Person
149 sg:pub.10.1007/bf00688324 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012150954
150 https://doi.org/10.1007/bf00688324
151 rdf:type schema:CreativeWork
152 sg:pub.10.1038/sj.bmt.1701506 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003184141
153 https://doi.org/10.1038/sj.bmt.1701506
154 rdf:type schema:CreativeWork
155 sg:pub.10.1038/sj.bmt.1703015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000251426
156 https://doi.org/10.1038/sj.bmt.1703015
157 rdf:type schema:CreativeWork
158 sg:pub.10.1038/sj.bmt.1703710 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008363585
159 https://doi.org/10.1038/sj.bmt.1703710
160 rdf:type schema:CreativeWork
161 sg:pub.10.1038/sj.bmt.1704252 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037479272
162 https://doi.org/10.1038/sj.bmt.1704252
163 rdf:type schema:CreativeWork
164 https://app.dimensions.ai/details/publication/pub.1082501496 schema:CreativeWork
165 https://app.dimensions.ai/details/publication/pub.1082689457 schema:CreativeWork
166 https://app.dimensions.ai/details/publication/pub.1082761874 schema:CreativeWork
167 https://app.dimensions.ai/details/publication/pub.1083343944 schema:CreativeWork
168 https://doi.org/10.1002/hep.1840190515 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024503731
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1016/0090-4295(82)90633-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035543523
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1016/0140-6736(93)91646-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029165763
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1016/j.bbmt.2005.06.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015726375
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1016/s1083-8791(03)00269-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051220843
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1016/s1083-8791(99)70006-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044483054
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1046/j.1365-2141.2000.02475.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1056733427
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1055/s-2002-23204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057413625
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1097/01.tp.0000230373.82376.46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050094293
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1182/blood.v98.6.1971 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034351793
187 rdf:type schema:CreativeWork
188 https://doi.org/10.3109/10428199909093722 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009274082
189 rdf:type schema:CreativeWork
190 https://doi.org/10.3324/haematol.10699 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017260245
191 rdf:type schema:CreativeWork
192 https://www.grid.ac/institutes/grid.31151.37 schema:alternateName Centre Hospitalier Regional Universitaire De Dijon
193 schema:name Department of Pediatrics, Hopital d'Enfants, Vandeouvre Les Nancy, France
194 rdf:type schema:Organization
195 https://www.grid.ac/institutes/grid.419504.d schema:alternateName Istituto Giannina Gaslini
196 schema:name Department Haematology/Oncology, G. Gaslini Children's Research Institute, Genoa, Italy
197 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...